May 1st 2024
The vice president of technology strategy & strategic partnerships at Syneos Health discusses how new digital technologies are changing the ways that data is collected, shared, analyzed.
EMA Launches Data Standards Implementation Guide: The Time to Act is Now
February 22nd 2021The European Medicines Agency (EMA) has published a guide to implementing IDMP data standards that will be ”a game changer” for the life sciences sector. Remco Munnik, who has been working with the EU focus group creating the EU IDMP Implementation Guide version 2, provides the inside track on the implications for life sciences companies.
How A Self-Service Data Platform for Life Sciences Analytics Can Fast-Track Drug Readiness
December 9th 2020Owning a self-service data platform allows emerging pharma and biotech companies to accelerate past data engineering intricacies and focus on ad-hoc analytics to discern how their data can help them meet objectives for clinical operations, medical affairs, and commercial teams.
How Biopharma Can Rev Up the Analytics Engine to Boost Patient Compliance
December 4th 2020While patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.
The Department of Justice is Watching: Building a Data-Driven Compliance Program
November 18th 2020Whether your company already has a data-driven compliance program in place or is contemplating building one, Michael O'Connor and Isha Arora outline four things the DOJ is now focused on that your compliance team needs to know.
Veeva Teams with Biopharma to Offer Industrywide Source for Key Contacts, Information, and Services
October 30th 2020Following the introduction this week MyVeeva for Doctors, Veeva’s Paul Shawah discusses the background to the product and the role biopharma companies will play in its ongoing development.
AI 2.0: The Humanizing of Machine Learning Technology
October 26th 2020Digital engagement is becoming the new normal, but it can inhibit the individual connection that is foundational to building long-term customer relationships. How can reps, brand teams, and medical science liaisons strike the right balance of personal and non-personal engagement? The next generation of AI has an answer, writes Derek Choy.